Rock Springs Capital Management, LP

Company	Share, %
Talphera Inc.	7.7
Inozyme Pharma, Inc.	5.96
Blueprint Medicines Corporation	4.71
Accolade, Inc.	4.5
Jasper Therapeutics, Inc.	3.93
Aclaris Therapeutics, Inc.	3.69
EDAP TMS S.A.	3.44
IMARA Inc.	3.2
Mersana Therapeutics, Inc.	3.05
AcelRx Pharmaceuticals, Inc.	1.94
Cerevel Therapeutics Holdings, Inc.	1.47
Olink Holding AB (publ)	1.35
Zai Lab Limited	0.72